Achiral Peptoids and Variations for Treating Alzheimer's Disease


Technology / 15-18:    Achiral Peptoids and Variations for Treating Alzheimer’s Disease

Inventor:                      Shannon L. Servoss, Melissa A. Moss, James Phillip Turner Jr.

Status:                        This invention is available for licensing


General Description

Alzheimer’s disease is a devastating disease that progressively robs the memory and the mental abilities of the patient. New peptoids have been created, by the University of Arkansas, that prevent the aggregation of the beta amyloids, and may break up existing amyloids. These new peptoids may be developed into drugs, which could be administered to Alzheimer’s patients to prevent further damage to their brains, and possibly even to reverse the effects of the disease.


  • Protease resistent
  • Cost-effective production
  • High bio availability
  • Flexible molecule
  • Low Immunogenicity 



  • Alzheimer's disease
  • All diseases associated with amyloids
  • Misfolding proteins
  • Biomarker detections for amytoid beta and Alzheimer's disease
  • A beta modulation
  • A beta inhibition
  • A beta aggregation reversal
  • Type Il Diabetes treatment
  • Autism treatment
  • Intranasal administration for neurodegenerative 



Alzheimer’s disease (AD) is sixth leading cause of death in the United States and the leading form of dementia worldwide.


For interested parties seeking further information, feel free to contact:


Mark Allen Lanoue

Technology Manager / Tech Ventures

University of Arkansas

(479) 575-7243


For additional information on the research, see this article



Patent Information:
App Type Country Serial No. Patent No. File Date Issued Date Expire Date
Provisional United States 62/184,057 6/24/2015    
For Information, Contact:
Mark Lanoue
Technology Manager
University of Arkansas
Shannon Servoss
James Turner
Melissa Moss
© 2020. All Rights Reserved. Powered by Inteum